shortagewatch

Home / Companies / Aurobindo

Company family · HQ IN

Aurobindo: medicine shortages

AUROPHARMA · NSE

As of 2 Nov 2026, 226 Aurobindo products have a reported shortage across 9 countries, covering 111 medicines.

Products short226rank #11 of 464
Medicines111active ingredients
Countries9/16
New in 90 days50-28 vs market pace
Typical duration7 monthsmedian so far
Manufacturing51%demand-driven 24%

Where

United States61Germany17France3Italy98Spain7Ireland3Belgium33Sweden3New Zealand1

Which therapeutic classes

Nervous system63Cardiovascular system50Cancer and immune system35Anti-infectives22Musculoskeletal system16Digestive tract and metabolism8Respiratory system8Dermatologicals6Genito-urinary system and sex hormones5Blood1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
AurobindoAurobindo: Manufacturing problem 91 (40%)40%Aurobindo: Increased demand 43 (19%)19%Aurobindo: Active ingredient shortage 6 (3%)Aurobindo: Commercial decision or withdrawal 2 (1%)Aurobindo: Regulatory or licensing 2 (1%)Aurobindo: Other 33 (15%)15%Aurobindo: Not stated 48 (21%)21%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

Open shortages over time

15015115115231 Oct2026-10-31: 1511 Nov2026-11-01: 1512 Nov2026-11-02: 151

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

06121825Dec: 0Jan ’25: 3Feb: 1FebMar: 0Apr: 0May: 1MayJun: 0Jul: 1Aug: 0AugSep: 4Oct: 3Nov: 2NovDec: 1Jan ’26: 1Feb: 3FebMar: 7Apr: 8May: 6MayJun: 18Jul: 18Aug: 8AugSep: 19Oct: 22Nov: 1Nov

Long-run trend in Canada

Canada dashboard
0257102024: 4420242025: 8820252026: 222026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Jamp151

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Aurobindo: 226 / 111Aurobindo

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Lidocaine1120 Feb 2018Not stated2/16
Etoricoxib929 May 2026Manufacturing problem7/16
Bupivacaine820 Feb 2018Not stated8/16
Ropivacaine723 Mar 2018Not stated9/16
Clonazepam610 Mar 2023Not stated4/16
Docetaxel43 Oct 2025Manufacturing problem8/16
Furosemide47 Apr 2020Not stated11/16
Irinotecan43 Jul 2023Other5/16
Meropenem411 Dec 2025Manufacturing problem6/16
Quinapril419 Jan 2023Manufacturing problem2/16
Terbinafine426 Aug 2026Other5/16
Azacitidine322 Dec 2020Increased demand6/16
Carboplatin328 Apr 2023Increased demand10/16
Carvedilol32 Apr 2026Not stated8/16
Dexmedetomidine310 Apr 2020Not stated4/16
Diazepam317 Jun 2026Increased demand7/16
Enalapril312 Feb 2024Manufacturing problem8/16
Olanzapine36 May 2026Manufacturing problem13/16
Oxaliplatin38 Mar 2026Manufacturing problem10/16
Paclitaxel31 Jun 2026Manufacturing problem7/16
Paracetamol39 Jul 2026Other10/16
Piperacillin and Beta-Lactamase Inhibitor320 Jul 2023Other8/16
Quetiapine316 Sep 2025Other12/16
Ramipril and Diuretics317 Nov 2025Manufacturing problem4/16
Venlafaxine330 Jul 2025Other10/16
Bendamustine221 Oct 2025Manufacturing problem7/16
Bezafibrate230 Jul 2026Other4/16
Bortezomib224 Apr 2026Increased demand5/16
Carbamazepine218 Nov 2026Manufacturing problem5/16
Entecavir226 Oct 2026Manufacturing problem8/16
Epirubicin217 Feb 2023Other7/16
Escitalopram222 Jun 2026Increased demand10/16
Etomidate25 Oct 2022Increased demand3/16
Febuxostat220 Mar 2026Manufacturing problem6/16
Flucloxacillin21 Aug 2020Manufacturing problem2/16
Gabapentin220 Jul 2026Manufacturing problem9/16
Levetiracetam21 Jun 2026Manufacturing problem9/16
Levocetirizine230 Jul 2026Manufacturing problem4/16
Linezolid229 Sep 2026Manufacturing problem7/16
Methylprednisolone215 Dec 2021Increased demand1/16
Rocuronium Bromide215 Feb 2023Not stated5/16
Ropinirole219 Jan 2025Manufacturing problem8/16
Sitagliptin29 Jun 2026Manufacturing problem8/16
Sumatriptan26 Jul 2026Manufacturing problem13/16
Tamsulosin and Solifenacin217 Apr 2026Other5/16
Telmisartan23 Sep 2026Manufacturing problem6/16
Topiramate216 Feb 2026Manufacturing problem8/16
Urapidil29 Feb 2026Manufacturing problem4/16
Valsartan and Diuretics227 Aug 2026Manufacturing problem7/16
Acarbose117 Aug 2026Manufacturing problem2/16
Almotriptan110 Aug 2026Manufacturing problem2/16
Amiodarone11 Sep 2026Manufacturing problem5/16
Amoxicillin130 Jul 2026Other7/16
Ampicillin and Beta-Lactamase Inhibitor11 Jun 2026Manufacturing problem1/16
Bicalutamide122 Jul 2026Increased demand6/16
Bilastine119 Apr 2026Manufacturing problem3/16
Bisoprolol115 Nov 2026Manufacturing problem6/16
Bisoprolol and Thiazides14 Nov 2026Increased demand2/16
Bromazepam119 Nov 2026Manufacturing problem4/16
Butylscopolamine14 Jun 2026Commercial decision or withdrawal3/16
Cabergoline114 Oct 2025Manufacturing problem4/16
Candesartan121 Apr 2026Manufacturing problem10/16
Cetirizine17 Oct 2026Increased demand4/16
Cinacalcet12 Oct 2026Increased demand11/16
Clozapine113 Aug 2026Manufacturing problem3/16
Desloratadine122 Jul 2026Manufacturing problem7/16
Dexamethasone18 Feb 2019Not stated1/16
Doxorubicin19 Oct 2026Increased demand8/16
Dronedarone110 Sep 2025Increased demand3/16
Ebastine15 May 2026Manufacturing problem4/16
Eletriptan115 Sep 2026Manufacturing problem7/16
Fingolimod11 Jun 2026Manufacturing problem9/16
Flecainide122 Oct 2026Increased demand5/16
Fulvestrant113 May 2025Not stated5/16
Hydroxycarbamide111 Nov 2025Increased demand2/16
Ibuprofen122 Dec 2026Manufacturing problem8/16
Ivabradine120 Oct 2026Manufacturing problem9/16
Lamivudine111 Sep 2025Increased demand3/16
Levofloxacin130 Sep 2024Increased demand4/16
Lisinopril121 Dec 2026Manufacturing problem5/16
Montelukast122 Dec 2026Manufacturing problem13/16
Moxifloxacin110 Sep 2026Manufacturing problem8/16
Naproxen119 Mar 2026Manufacturing problem6/16
Nintedanib117 Sep 2026Not stated4/16
Olmesartan Medoxomil19 Dec 2026Increased demand5/16
Olmesartan Medoxomil and Diuretics18 Oct 2026Manufacturing problem4/16
Omega-3-Triglycerides Incl. Other Esters and Acids113 Apr 2026Increased demand1/16
Oxycodone121 Dec 2026Manufacturing problem6/16
Pantoprazole13 Jan 2024Other9/16
Pioglitazone11 Jun 2026Manufacturing problem7/16
Pirfenidone129 Oct 2026Manufacturing problem6/16
Plerixafor123 Sep 2026Not stated7/16
Ramipril130 Nov 2026Not stated10/16
Repaglinide130 Jun 2026Manufacturing problem5/16
Risedronic Acid125 Sep 2026Increased demand3/16
Ritonavir16 May 2026Not stated6/16
Rivastigmine18 Oct 2026Manufacturing problem6/16
Rizatriptan118 Nov 2026Manufacturing problem6/16
Rosuvastatin18 Oct 2026Manufacturing problem12/16
Rupatadine130 Sep 2026Increased demand3/16
Sertraline110 Sep 2026Manufacturing problem11/16
Sevelamer18 Nov 2026Manufacturing problem5/16
Sildenafil115 Sep 2026Manufacturing problem10/16
Silodosin111 Sep 2026Other4/16
Simvastatin and Ezetimibe114 Jun 2026Increased demand8/16
Tenofovir Disoproxil and Emtricitabine125 Oct 2026Increased demand5/16
Timolol, Combinations123 Mar 2026Increased demand9/16
Tranexamic Acid129 Sep 2025Manufacturing problem10/16
Valaciclovir122 Oct 2026Manufacturing problem10/16
Vinorelbine110 Jun 2026Not stated5/16
Voriconazole19 Oct 2026Increased demand6/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.